Jae Young PARK

Mr. Jae Young PARK

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in Journal of Clinical Neurology
Verified
Journal Article
Open access
PDF file
SJSoo Jeong
Soo Jeong
DLDongwhane Lee
Dongwhane Lee
HKHyuk Sung Kwon
Hyuk Sung Kwon
DLDeok Hee Lee
Deok Hee Lee
SHSang Hee Ha
Sang Hee Ha
BKBum Joon Kim
Bum Joon Kim
Jeong S, et al. J Clin Neurol. 2026 Jan;22(1):50-58. https://doi.org/10.3988/jcn.2025.0216

30 October 2020 in Annals of Clinical Neurophysiology
Verified
Journal Article
Open access
PDF file
JPJae Young PARK
Jae Young PARK
HJHoe Jong Jung
Hoe Jong Jung
HBHeewon Bae
Heewon Bae
JHJeong-Ho Han
Jeong-Ho Han
MKMin Ju Kang
Min Ju Kang
Miller Fisher syndrome (MFS) is characterized by the acute ophthalmoparesis, ataxia and areflexia. We describe the case of 70-year-old man with cardinal symptom of MFS and active pulmonary tuberculosis (Tb). A thorough evaluation led to the diagnosis of MFS and treatment with intravenous immunoglobulin (IVIg) was started. The complete resolution of ophthalmoparesis and ataxia was observed from the fourth day of IVIg treatment. This is the first report to describe a case of MFS that developed in patient pulmonary tuberculosis.

1 January 2019 in Dementia and Neurocognitive Disorders
Verified
Journal Article
Open access
PDF file
HBHeewon Bae
Heewon Bae
JPJae Young PARK
Jae Young PARK
YYYoungSoon Yang
YoungSoon Yang
Bae H, et al. Dement Neurocogn Disord. 2019 Mar;18(1):30-32. https://doi.org/10.12779/dnd.2019.18.1.30

15 April 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
JCJun Young Chang
Jun Young Chang
JPJae Young PARK
Jae Young PARK
JSJeong Yun Song
Jeong Yun Song
JYJun Sang Yoo
Jun Sang Yoo
KLKyu Bong Lee
Kyu Bong Lee
HYO SUK NAMHYO SUK NAM
HYO SUK NAM
Background: We investigated whether the association between blood pressure (BP) management in patients with successful reperfusion following endovascular therapy (EVT) and functional outcomes is mediated by BP variability parameters. Methods and Results: This is a post hoc analysis of the OPTIMAL‐BP (Outcome in Patients Treated With Intra‐Arterial Thrombectomy‐Optimal Blood Pressure Control) trial, conducted at 19 centers in South Korea. The primary outcome was the 90‐day functional outcome, assessed using the modified Rankin Scale. Multivariable logistic regression analysis was conducted for the association between BP variability and outcomes including 90‐day modified Rankin Scale score, symptomatic intracranial hemorrhage, and final infarction volume. Mediation analysis was performed to evaluate the causal inference whether the relationship between intensive BP management and the 90‐day modified Rankin Scale scoreis mediated by 24‐hour BP variability parameters (time rate [TR], SD, coefficient of variation, and variability independent of the mean). Among various BP variability parameters, higher TR was associated with an unfavorable ordinal shift of the 90‐day modified Rankin Scale score (adjusted odds ratio [aOR], 1.17 [95% CI, 1.04–1.32], P =0.007) and an increase in final infarction volume ( β $$ \beta $$ coefficient, 21.24 [95% CI, 3.99–38.48], P =0.016), but did not increase the risk of symptomatic intracranial hemorrhage. TR fully mediated the association between intensive BP management and functional outcomes. The proportion of the association explained by TR was 40.93%. Conclusions: TR mediated the relationship between intensive BP management and poor functional outcome in successfully reperfused patients with ischemic stroke by contributing to an increase in infarct volume. Efforts to modulate TR after EVT may be helpful in improving clinical outcomes.

31 December 2023 in Journal of Neurosonology and Neuroimaging
Verified
Journal Article
Open access
PDF file
SKSeung Min Kim
Seung Min Kim
JPJae Young PARK
Jae Young PARK
SHSang Hee Ha
Sang Hee Ha
BKBum Joon Kim
Bum Joon Kim
Identifying the stroke mechanism is crucial for secondary prevention of ischemic stroke. However, approximately 20% to 30% of patients with ischemic stroke do not display a discernible cause after standard diagnostic evaluation and are classified as having cryptogenic stroke. Most cryptogenic strokes are believed to be of embolic origin, referred to as embolic stroke of undetermined source. Several potential causes, including occult atrial fibrillation, aortic arch atheroma, non-stenotic atherosclerosis, coagulopathy, and patent foramen ovale (PFO), are significant contributors to cryptogenic stroke. Among these, PFO-associated strokes often manifest as small cortical lesions in the posterior circulation and are associated with fewer traditional risk factors. Ischemic stroke is considered a high risk if there is a large PFO with significant shunting or the presence of an atrial septal aneurysm. Although transesophageal echocardiography is regarded as the gold standard for diagnosing PFO, its invasiveness, high cost, and challenges in certain stroke patients necessitate alternative approaches. Recently, transcranial Doppler (TCD) has emerged as a valuable screening tool for detecting high-risk PFOs, as supported by recent research. Accurate determination of the culprit PFO responsible for ischemic stroke remains crucial for guiding appropriate treatment decisions. This article provides a comprehensive review of the different modalities used to diagnose PFO, strategies for assessing the risk of PFO causing paradoxical embolism, and the role of TCD in patients with cryptogenic stroke caused by other etiologies.

1 January 2024 in Journal of Clinical Neurology
Verified
Journal Article
Open access
PDF file
JPJae Young PARK
Jae Young PARK
SHSang Hee Ha
Sang Hee Ha
SJSoo Jeong
Soo Jeong
JCJun Young Chang
Jun Young Chang
DKDong-Wha Kang
Dong-Wha Kang
BKBum Joon Kim
Bum Joon Kim
Park JY, et al. J Clin Neurol. 2024 Aug;20:e62. https://doi.org/10.3988/jcn.2024.0139